These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20635587)

  • 1. Myasthenic crisis as a side effect of methimazole therapy: case report.
    Baretić M; Balić S; Gudelj G
    Acta Clin Croat; 2010 Mar; 49(1):67-71. PubMed ID: 20635587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of methimazole on warfarin anticoagulation in a case of Graves' disease.
    Akin F; Yaylali GF; Bastemir M; Yapar B
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):89-91. PubMed ID: 18180622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated myasthenia gravis in a methimazole-treated cat.
    Bell ET; Mansfield CS; James FE
    J Small Anim Pract; 2012 Nov; 53(11):661-3. PubMed ID: 22957965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three patients who spontaneously developed persistent hypothyroidism during or following treatment with antithyroid drugs for Graves' hyperthyroidism.
    Shigemasa C; Mitani Y; Taniguchi S; Adachi T; Ueta Y; Urabe K; Miyazaki S; Tanaka T; Yoshida A; Mashiba H
    Arch Intern Med; 1990 May; 150(5):1105-9. PubMed ID: 1691909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs.
    Suzuki S; Ichikawa K; Nagai M; Mikoshiba M; Mori J; Kaneko A; Sekine R; Asanuma N; Hara M; Nishii Y; Yamauchi K; Aizawa T; Hashizume K
    Arch Intern Med; 1997 Mar; 157(6):693-6. PubMed ID: 9080924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methimazole-induced cholestatic jaundice in an elderly hyperthyroid patient.
    Ramos-Bonner LS; Goldberg TH; Moyer S; Anastasopoulou C
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):236-40. PubMed ID: 17996663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case report of mucormycosis in a patient with secondary methimazole-induced agranulocytosis].
    Ramírez C; Hernández AF; Méndez V; Trejo S; Contreras R; Espinosa de los Monteros AL; Gómez LM; Mercado M
    Gac Med Mex; 2009; 145(3):235-8. PubMed ID: 19685830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
    Dai W; Zhang J; Zhan Z; Xu B; Jin H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methimazole-induced cholestatic jaundice in a hyperthyroid patient].
    López-P Rdel P; Forero JD; Sierra F
    Acta Gastroenterol Latinoam; 2014 Mar; 44(1):52-8. PubMed ID: 24847631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudo-myasthenia gravis and thymic hyperplasia in Graves' disease.
    Nicolle MW
    Can J Neurol Sci; 1999 Aug; 26(3):201-3. PubMed ID: 10451743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Graves' disease and methimazole on warfarin anticoagulation.
    Busenbark LA; Cushnie SA
    Ann Pharmacother; 2006 Jun; 40(6):1200-3. PubMed ID: 16735660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe pancytopenia associated with antithyroid drugs in a patient with Graves' disease and chronic renal failure.
    Macia M; Méndez M; Fernández J; Riverol A; Rios
    Clin Nephrol; 1997 Feb; 47(2):129. PubMed ID: 9049463
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA; Tötterman TH
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Side effects of antithyroid therapy of hyperthyroidism. A study of 1256 continuously treated patients].
    Meyer-Gessner M; Benker G; Olbricht T; Windeck R; Cissewski K; Reiners C; Reinwein D
    Dtsch Med Wochenschr; 1989 Feb; 114(5):166-71. PubMed ID: 2464468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methimazole treatment in Graves' disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets.
    Paggi A; Amoroso A; Ferri GM; Mariotti A; Pellegrino C; Afeltra A
    Eur Rev Med Pharmacol Sci; 1998; 2(1):11-9. PubMed ID: 9825565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of the major peripheral blood T, B and NK cell subsets does not predict the clinical outcome of Graves' disease patients after methimazole therapy.
    Corrales JJ; López A; Ciudad J; Orfao A
    J Biol Regul Homeost Agents; 2000; 14(3):193-9. PubMed ID: 11037052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy.
    Sugimoto K; Sasaki M; Isobe Y; Tamayose K; Hieda M; Oshimi K
    Eur J Haematol; 2005 Jan; 74(1):73-4. PubMed ID: 15613111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.